Your Article Summary
See Latest ArticlesMulticenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections
Antimicrobial Agents and Chemotherapy, 06/26/09
Krievins D et al. - Iclaprim exhibited a safety profile similar to that of vancomycin, an established drug for the treatment of cSSSI. Results from this study indicate that iclaprim is a promising new therapy for the treatment of cSSSI, in particular those caused by S. aureus, including MRSA.
Related Articles
In Vitro Bactericidal Activity of Iclaprim in Human Plasma
Antimicrobial Agents and Chemotherapy, 10/09/09
Relevance Score: 87%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/16/09
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Bacterial Burden of Worn Therapeutic Silver Textiles for Neurodermitis Patients and Evaluation of Efficacy of Washing
Skin Pharmacology and Applied Skin Physiology, 12/16/09
The period prevalence of oral lichen planus in a cohort of patients with vulvar lichen sclerosus
Journal of the European Academy of Dermatology and Venereology, 12/16/09
Clinically relevant drug interactions of current antifungal agents
Mycoses, 12/15/09